Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2026 07:30 ET | Source: Mobilicom Limited

Mobilicom Launches SkyHopper MultiBand: Delivering Cybersecure, Expansive Wideband Coverage for Loitering Drones and Robotics

MultiBand technology designed to further expand SkyHopper SDR DataLinks product line with wider spectrum, longer range, and robust electronic warfare resilience Unified configuration aimed at...
March 05, 2026 07:30 ET | Source: Wrap Technologies, Inc.

Panama Partner Issues Purchase Order for DFR-X Drone System as Wrap Expands Non-Lethal Response Capabilities in the Region

Initial order includes drone platform and Non-Lethal Response technologies including BolaWrap devices to support modern public safety operations in Panama.
March 05, 2026 07:30 ET | Source: Biogen Inc.

Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences

Long-term data from DEVOTE/ONWARD studies show benefits of high dose nusinersen in people living with spinal muscular atrophy (SMA)New Phase 1b data further illustrate potential of salanersen in SMA,...
March 05, 2026 07:30 ET | Source: ASP Isotopes Inc.

Quantum Leap Energy Appoints Nate Salpeter, Ph.D., a Key Opinion Leader in Fluid Dynamics and Energy Technology, as its Chief Technology Officer

DALLAS, March 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“QLE” or the “Company”), a wholly-owned subsidiary of ASPI...
March 05, 2026 07:30 ET | Source: Helus Pharma

Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder

Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 points on top of Standard of Care (“SoC”) at 6 weeksDurable effects...
March 05, 2026 07:30 ET | Source: Medicus Pharma Ltd

Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort

PHILADELPHIA, March 05, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...
March 05, 2026 07:30 ET | Source: CervoMed Inc.

CervoMed to Participate in Upcoming Investor Conferences

BOSTON, March 05, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders, today announced that Company...
March 05, 2026 07:30 ET | Source: CorMedix, Inc.

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

‒ Q4 2025 Net Revenue of $128.6 million ‒ ‒ Pro Forma Full Year 2025 Net Revenue of $401.3 million ‒ ‒ Q4 2025 Net Income of $14.0 million; Adjusted EBITDA of $77.2 million ‒ ‒ Conference Call...
March 05, 2026 07:30 ET | Source: Compass Therapeutics

Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update

In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified event threshold of 80% overall survival (OS) events was...
March 05, 2026 07:12 ET | Source: Gilat Satellite Networks Ltd.

Gilat to Highlight Next‑Generation Satellite Connectivity Technologies at Satellite 2026 – “Expanding 5G to Space”

PETAH TIKVA, Israel, March 05, 2026 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...